Cyt107    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
25Progressive multifocal leukoencephalopathy3

25. Progressive multifocal leukoencephalopathy    [ 23 clinical trials,   33 drugs,   (DrugBank: 20 drugs),   7 drug target genes,   36 drug target pathways]
Searched query = "Progressive multifocal leukoencephalopathy", "PML", "Leukoencephalopathy, progressive multifocal"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
3 / 23 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2012-000725-41-GB
(EUCTR)
22/01/201304/09/2012A randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal LeukoencephalopathyA randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal Leukoencephalopathy. - INVICTUS HIV-infected patients with Progressive Multifocal Leukoencephalopathy
MedDRA version: 15.0;Level: PT;Classification code 10036807;Term: Progressive multifocal leukoencephalopathy;System Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]
Product Name: Recombinant human interleukin-7
Product Code: CYT107
INN or Proposed INN: N/A
Other descriptive name: Recombinant human interleukin-7
Cytheris S.A.NULLNot RecruitingFemale: yes
Male: yes
57Phase 2bUnited States;European Union;Spain;Italy;Switzerland;United Kingdom
2EUCTR2012-000725-41-ES
(EUCTR)
12/12/201214/09/2012A randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal LeukoencephalopathyA randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal Leukoencephalopathy. - INVICTUS HIV-infected patients with Progressive Multifocal Leukoencephalopathy
MedDRA version: 15.0;Level: PT;Classification code 10036807;Term: Progressive multifocal leukoencephalopathy;System Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]
Product Name: Recombinant human interleukin-7
Product Code: CYT107
INN or Proposed INN: N/A
Other descriptive name: Recombinant human interleukin-7
Cytheris S.A.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
57Phase 2bUnited States;European Union;Spain;United Kingdom;Switzerland
3EUCTR2012-000725-41-IT
(EUCTR)
08/11/201211/12/2012A randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal LeukoencephalopathyA randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal Leukoencephalopathy - INVICTUS HIV-infected patients with Progressive Multifocal Leukoencephalopathy
MedDRA version: 14.1;Level: SOC;Classification code 10021881;Term: Infections and infestations;System Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]
Product Name: Recombinant human interleukin-7
Product Code: CYT107
Other descriptive name: Recombinant human interleukin-7
CYTHERISNULLNot RecruitingFemale: yes
Male: yes
57Phase 2bUnited States;Spain;United Kingdom;Switzerland;Italy